Association Between Pulse Wave Velocity and Frailty, Disability, and Mortality in Community-Dwelling Older Adults
| dc.contributor.affiliation | Instituto de Salud Carlos III | |
| dc.contributor.affiliation | Hospital Universitario de Getafe | |
| dc.contributor.affiliation | Complutense University of Madrid | |
| dc.contributor.affiliation | Universidad de Las Americas - Chile | |
| dc.contributor.affiliation | Complejo Hospitalario de Toledo | |
| dc.contributor.author | Alvarez-Bustos, Alejandro | |
| dc.contributor.author | Carnicero, Jose A. | |
| dc.contributor.author | Rodriguez-Sanchez, Beatriz | |
| dc.contributor.author | El-Assar, Mariam | |
| dc.contributor.author | Rueda, Ricardo | |
| dc.contributor.author | Pereira, Suzette L. | |
| dc.contributor.author | Sepulveda-Loyola, Walter | |
| dc.contributor.author | Garcia-Garcia, Francisco J. | |
| dc.contributor.author | Sulo, Suela | |
| dc.contributor.author | Rodriguez-Manas, Leocadio | |
| dc.date.accessioned | 2024-09-03T19:20:29Z | |
| dc.date.available | 2024-09-03T19:20:29Z | |
| dc.date.issued | 2023-07 | |
| dc.description.abstract | BACKGROUND Arterial stiffness leads to several adverse events in the older population, but there is a lack of data on its association with frailty, disability, and mortality in the same population. OBJECTIVES The purpose of this study was to evaluate the role of arterial stiffness in the loss of functional ability (frailty and disability) and mortality. METHODS Data were taken from community-dwelling aged 65 years participants without diabetes in the Toledo Study of Healthy Ageing cohort. Pulse wave velocity (PWV), assessed through SphygmoCor, was recorded at baseline. Median followup time were 2.99 years for frailty (frailty phenotype [FP] and Frailty Trait Scale-5 [FTS5]) and disability (Katz Index) and 6.2 for mortality. Logistic regressions models were built for disability and frailty and Cox proportional hazards model for death, adjusted by age and sex, comorbidity, cardiovascular risk factors, asymmetric dimethylarginine levels, and polypharmacy. RESULTS Overall, 978 (mean age 74.5 f 5.6 years, 56.7% female) participants were included. Different cut-off points were shown for each outcome. PWV >11.5 m/s was cross-sectionally associated with frailty (FP: OR fully-adjusted model: 1.69,95% CI: 1.45-1.97; FTS5: OR: 1.51, 95% CI: 1.22-1.87) and disability (OR: 1.51, 95% CI: 1.26-1.79); PWV >10 m/s with incident frailty by FP (OR: 1.36, 95% CI: 1.10-1.68) and FTS5 (OR: 1.40, 95% CI: 1.12-1.75), and PWV >11 m/s with death (HR: 1.28, 95% CI: 1.09-1.50). For incident (OR: 1.28, 95% CI: 1.06-1.55) and worsening disability (OR: 1.21, 95% CI: 1.02-1.45) the threshold was 12.5 m/s. Below these cut-off points, age was the best predictor of adverse outcomes. CONCLUSIONS Arterial stiffness predicts frailty, disability, and mortality in older people, with different cut-off points, ie,severity degrees, for each of the assessed outcomes. | |
| dc.description.sponsorship | Abbott - Spanish Ministry of Economy, Industry and Competitiveness; European Regional Development Funds (Instituto de Salud Carlos III) [PI20/009 77]; Innovative Medicines Initiative Joint Undertaking [11562 1]; European Union; EFPIA companies; Centro de Investigacion Biomedica en Red en Fragilidad y Envejecimiento Saludable [CB16/10/00464]; Financial support for this analysis was provided by Abbott. TSHA research was funded by grants from the Spanish Ministry of Economy, Industry and Competitiveness, cofinanced by the European Regional Development Funds (Instituto de Salud Carlos III, PI20/009 77) and the Centro de Investigacion Biomedica en Red en Fragilidad y Envejecimiento Saludable (CB16/10/00464) ; the MITOFUN Project, Fundacion Francisco Soria Melguizo (Section 2/2020) ; Innovative Medicines Initiative Joint Undertaking under grant agreement np 11562 1, resources of which are composed of financial contribution from the European Union' Seventh Framework Programme (FP7/2007-2013) and EFPIA companies. Drs Rueda, Pereira, Sul o are employees of Abbott. Dr Rodriguez-Maras has received funds as a speaker in Abbott-supported conferences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | JACC: Advances, 2(5), 100423. https://doi.org/10.1016/j.jacadv.2023.100423 | |
| dc.identifier.doi | https://doi.org/10.1016/j.jacadv.2023.100423 | |
| dc.identifier.issn | 2772-963X | |
| dc.identifier.orcid | https://orcid.org/0000-0003-3690-6069 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-5537-9201 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-3431-7204 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-6146-068X | |
| dc.identifier.pmid | 38939008 | |
| dc.identifier.researcherid | R-9258-2017 | |
| dc.identifier.researcherid | G-7400-2018 | |
| dc.identifier.researcherid | GYU-8290-2022 | |
| dc.identifier.researcherid | AFL-1127-2022 | |
| dc.identifier.ror | https://ror.org/00ca2c886 | |
| dc.identifier.ror | https://ror.org/04j0sev46 | |
| dc.identifier.ror | https://ror.org/01ehe5s81 | |
| dc.identifier.ror | https://ror.org/02p0gd045 | |
| dc.identifier.ror | https://ror.org/01w8r0j67 | |
| dc.identifier.ror | https://ror.org/0052svj16 | |
| dc.identifier.ror | https://ror.org/00p99t114 | |
| dc.identifier.ror | https://ror.org/0166e9x11 | |
| dc.identifier.ror | https://ror.org/00kxqbw45 | |
| dc.identifier.scopusauthorid | 57201487862 | |
| dc.identifier.scopusauthorid | 57205090636 | |
| dc.identifier.scopusauthorid | 57189626078 | |
| dc.identifier.scopusauthorid | 11240850700 | |
| dc.identifier.scopusauthorid | 7004295136 | |
| dc.identifier.scopusauthorid | 7202024688 | |
| dc.identifier.scopusauthorid | 58289745600 | |
| dc.identifier.scopusauthorid | 57199662920 | |
| dc.identifier.scopusauthorid | 55367700400 | |
| dc.identifier.scopusauthorid | 7004685679 | |
| dc.identifier.uri | https://repositorio.udla.cl/handle/udla/1501 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier BV | |
| dc.relation.funding | Fundación Francisco Soria Melguizo | |
| dc.relation.funding | Abbott Laboratories | |
| dc.relation.funding | Seventh Framework Programme, FP7 | |
| dc.relation.funding | Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable, CIBERFES, (CB16/10/00464) | |
| dc.relation.funding | Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable, CIBERFES | |
| dc.relation.funding | European Federation of Pharmaceutical Industries and Associations, EFPIA | |
| dc.relation.funding | Instituto de Salud Carlos III, ISCIII, (PI20/00977) | |
| dc.relation.funding | Instituto de Salud Carlos III, ISCIII | |
| dc.relation.funding | European Regional Development Fund, ERDF | |
| dc.relation.funding | Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España, MINECO | |
| dc.relation.funding | Innovative Medicines Initiative, IMI, (115621) | |
| dc.relation.funding | Innovative Medicines Initiative, IMI | |
| dc.relation.funding | Abbott - Spanish Ministry of Economy, Industry and Competitiveness | |
| dc.relation.funding | European Regional Development Funds (Instituto de Salud Carlos III) [PI20/009 77] | |
| dc.relation.funding | Innovative Medicines Initiative Joint Undertaking [11562 1] | |
| dc.relation.funding | European Union | |
| dc.relation.funding | EFPIA companies | |
| dc.relation.funding | Centro de Investigacion Biomedica en Red en Fragilidad y Envejecimiento Saludable [CB16/10/00464] | |
| dc.relation.isindexedby | Web of Science | |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | https://www.elsevier.com/tdm/userlicense/1.0/ | |
| dc.source | JACC: Advances | |
| dc.source.uri | https://www.sciencedirect.com/science/article/pii/S2772963X2300282X | |
| dc.subject | disability | |
| dc.subject | frailty | |
| dc.subject | mortality | |
| dc.subject | older adults | |
| dc.subject | pulse wave velocity (PWV) | |
| dc.subject.lcsh | Mortalidad | |
| dc.subject.lcsh | Ancianos | |
| dc.subject.oecd1 | 3 Ciencias Médicas y de la Salud | |
| dc.subject.oecd2 | 3.2 Medicina Clínica | |
| dc.subject.oecd3 | 3.2.4 Sistema Cardiovascular y Cardíaco | |
| dc.title | Association Between Pulse Wave Velocity and Frailty, Disability, and Mortality in Community-Dwelling Older Adults | |
| dc.title.alternative | Association Between Pulse Wave Velocity and Frailty, Disability, and Mortality in Community-Dwelling Older Adults. | |
| dc.type | journal article | |
| dc.type.coar | http://purl.org/coar/resource_type/c_6501 | |
| dc.type.driver | info:eu-repo/semantics/article | |
| dc.udla.catalogador | CBM | |
| oaire.citation.issue | 5 | |
| oaire.citation.title | JACC: Advances | |
| oaire.citation.volume | 2 | |
| udla.curacion.control | jmvg | |
| udla.oecd.area | 3 Ciencias Médicas y de la Salud | |
| udla.oecd.discipline | 3.2.4 Sistema Cardiovascular y Cardíaco | |
| udla.oecd.subarea | 3.2 Medicina Clínica |
Files
Original bundle
1 - 1 of 1